v. 15 – Q3 2020
See also UAE.
|Market Executive Summary||The State of Qatar is following the common practice for the Gulf countries towards drug traceability using the GS1 Standards, aligning on the use of GS1 DataMatrix with 4 data elements.
Note that industry reports a high degree of uncertainty, with the compliance deadlines in some instances not being enforced. The advice from Excellis to our customers is to ensure that:
In May 2020, the Ministry of Public Health issued a tender to establish a comprehensive National system for tracking and tracing of pharmaceuticals throughout the entire pathway from manufacturer(s) / port of entry to the dispensing of the product to the patient; supporting the sector’s strategic, regulatory, and patient safety objectives. This will presumably align with the published compliance dates, but no further details are known at this time.